Kettle Hill Capital Management, LLC Viatris Inc Transaction History

Kettle Hill Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Dec 08, 2022	SELL	$9.95 - $12.27 $6.31 Million - $7.79 Million	-634,531 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $19.6 Million - $30.8 Million	-2,001,940 Reduced 75.93%	634,531 $6.9 Million
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $17.5 Million - $21.3 Million	1,451,576 Added 122.51%	2,636,471 $35.7 Million
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $3.73 Million - $4.26 Million	-281,497 Reduced 19.2%	1,184,895 $16.1 Million
Q2 2021 Aug 16, 2021	BUY	$12.97 - $16.15 $12 Million - $14.9 Million	923,260 Added 169.99%	1,466,392 $21 Million
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $8.94 Million - $12.2 Million	-658,056 Reduced 54.78%	543,132 $7.59 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $17.2 Million - $22.5 Million	1,201,188 New	1,201,188 $22.5 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Kettle Hill Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kettle Hill Capital Management, LLC with notifications on news.